Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maurel

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2013
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancerA L Cohn, J Tabernero, J Maurel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE studyM Tempero, D-Y Oh, J Tabernero, et al.
Gastroenterologia Y Hepatologia|April 2, 2004
[Hospital registry of pancreatic tumors. Experience of the Hospital Clínic in Barcelona (Spain)]A Soriano-Izquierdo, A Castells, M Pellisé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2026
Survival outcomes in POD1UM-303/InterAACT-2: a phase 3 study of retifanlimab plus carboplatin-paclitaxel in first-line advanced squamous anal cancerS Rao, E Samalin-Scalzi, L Evesque, et al.
Gastroenterologia Y Hepatologia|December 3, 2002
[Evaluation of the efficacy and efficiency of a multidisciplinary unit for the treatment of patients with colorectal cancer]A Soriano, A Castells, A M Lacy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 9, 2015
Chikungunya outbreak in Montpellier, France, September to October 2014E Delisle, C Rousseau, B Broche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) StudyJ Martin-Broto, A Gutierrez, X Garcia-Del-Muro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2005
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMOJ-Y Blay, S Bonvalot, P Casali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2018
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer typesL Paré, T Pascual, E Seguí, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2013
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancerA L Cohn, J Tabernero, J Maurel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE studyM Tempero, D-Y Oh, J Tabernero, et al.
Gastroenterologia Y Hepatologia|April 2, 2004
[Hospital registry of pancreatic tumors. Experience of the Hospital Clínic in Barcelona (Spain)]A Soriano-Izquierdo, A Castells, M Pellisé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2026
Survival outcomes in POD1UM-303/InterAACT-2: a phase 3 study of retifanlimab plus carboplatin-paclitaxel in first-line advanced squamous anal cancerS Rao, E Samalin-Scalzi, L Evesque, et al.
Gastroenterologia Y Hepatologia|December 3, 2002
[Evaluation of the efficacy and efficiency of a multidisciplinary unit for the treatment of patients with colorectal cancer]A Soriano, A Castells, A M Lacy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 9, 2015
Chikungunya outbreak in Montpellier, France, September to October 2014E Delisle, C Rousseau, B Broche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) StudyJ Martin-Broto, A Gutierrez, X Garcia-Del-Muro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2005
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMOJ-Y Blay, S Bonvalot, P Casali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2018
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer typesL Paré, T Pascual, E Seguí, et al.
Pageof 9